Live feed08:05:00·87dPRReleasevia QuantisnowSCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan PotassiumByQuantisnow·Wall Street's wire, on your screen.SCNX· Scienture Holdings Inc.Health Care
